Chelation therapy of manganese intoxication with para-aminosalicylic acid (PAS) in Sprague-Dawley rats

NeuroToxicology

Volumn 30, Issue 2, 2009, Pages 240-248

  Zheng, Wei ^a   Jiang, Yue Ming ^b   Zhang, Yanshu ^a   Jiang, Wendy ^a   Wang, Xueqian ^a   Cowan, Dallas M ^a  

^a PURDUE UNIVERSITY   (United States)

^b GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Chelation cerebrospinal fluid; Choroid plexus; Copper; Iron; Manganese; Manganism; Para aminosalicylic acid or PAS; Striatum

Indexed keywords

AMINOSALICYLIC ACID; COPPER; IRON; MANGANESE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; BODY FLUID; BRAIN; BRAIN REGION; CEREBROSPINAL FLUID; CHELATION THERAPY; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; ERYTHROCYTE; HEART; INTOXICATION; LIVER; MALE; NONHUMAN; PANCREAS; PRIORITY JOURNAL; RAT; SOFT TISSUE; SPLEEN; SPRAGUE DAWLEY RAT; ANIMAL; COMPARATIVE STUDY; DRUG EFFECTS; MANGANESE POISONING; METABOLISM; PHYSIOLOGY; PROCEDURES; TISSUE DISTRIBUTION; TOXICITY;

ANIMALIA; RATTUS;

AMINOSALICYLIC ACID; ANIMALS; CHELATION THERAPY; MALE; MANGANESE; MANGANESE POISONING; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION;

EID: 61949131895     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuro.2008.12.007     Document Type: Article

References (60)

1. Aschner M., and Aschner J.L. Manganese transport across the blood-brain barrier: relationship to iron homeostasis. Brain Res Bull 24 (1990) 857-860
2. Aschner M., Nass R., Guilarte T.R., Schneider J.S., Zheng W., and Manganese:. Recent advances in understanding its transport and neurotoxicity. Toxicol Appl Pharmacol 221 (2007) 131-147
3. Bowler R.M., Gysens S., Diamond E., Nakagawa S., Drezgic M., and Roels H.A. Manganese exposure: neuropsychological and neurological symptoms and effects in welders. NeuroToxicology 27 (2006) 315-326
4. Calne D.B., Chu N.S., Huang C.C., Lu C.S., and Olanow W. Manganism and idiopathic Parkinsonism: similarities and differences. Neurology 44 (1994) 1583-1586
5. Chandra S.V., Shukla G.S., Srivastawa R.S., Singh H., and Gupta V.P. An exploratory study of manganese exposure to welders. Clin Toxicol 18 (1981) 407-416
6. Cook D.G., Fahn S., and Brait K.A. Chronic manganese intoxication. Arch Neurol 30 (1974) 59-64
7. Couper J. On the effects of black oxide of manganese when inhaled into the lungs. Brit Ann Med Pharm Vital Stat Gen Sci 1 (1837) 41-42
8. Crossgrove J.S., and Zheng W. Manganese toxicity upon overexposure. NMR Biomed (2004) 17544-17553
9. Fenstermacher J., and Kaye T. Drug diffusion within the brain. Ann NY Acad Sci 531 (1988) 29-39
10. Gavin C.E., Gunter K.K., and Gunter T.E. Manganese and calcium transport in mitochondria: implications for manganese toxicity. NeuroToxicology 20 (1999) 445-454
11. Guilarte T.R., Chen M.-K., McGlothan J.L., Verina T., Wong D.F., Zhou Y., et al. Nigrostriatal dopamine system dysfunction and subtle motor deficits in manganese-exposed non-human primates. Exp Neurol 202 (2006) 381-390
12. 2EDTA. NeuroToxicology 27 (2006) 333-339
13. Huang C.C., Chu N.S., Lu C.S., Wang J.D., Tsai J.L., Tzeng J.L., et al. Chronic manganese intoxication. Arch Neurol 46 (1989) 1104-1106
14. Huang C.C., Lu C.S., Chu N.S., Hochberg F., Lilienfeld D., Olanow W., et al. Progression after chronic manganese exposure. Neurology 43 (1993) 1479-1483
15. Jiang Y.-M., Mo X.-A., Du F.Q., Fu X., Zhu X.-Y., Gao H.-Y., et al. Effective treatment of manganese-induced occupational Parkinsonism with p-aminosalicylic acid: a case of 17-year follow-up study. J Occup Environ Med 48 (2006) 644-649
16. Jiang Y.-M., Zheng W., Long L.-L., Zhao W.-J., Li X.-G., Mo X.-A., et al. Brain magnetic resonance imaging and manganese concentrations in red blood cells of smelting workers: search for biomarkers of manganese exposure. NeuroToxicology 28 (2007) 126-135
17. Kalia K., Jiang W., and Zheng W. Manganese accumulates primarily in nuclei of cultured brain cells. NeuroToxicology 29 (2008) 466-470
18. Kim Y. Neuroimaging in manganism. NeuroToxicology 27 (2006) 369-372
19. Koller W.C., Lyons K.E., and Truly W. Effect of levodopa treatment of Parkinsonism in welders: a double-blind study. Neurology 62 (2004) 730-733
20. Ky S.-Q., Deng H.-S., Xie P.-Y., and Hu W. A report of two cases of chronic serious manganese poisoning treated with sodium para-aminosalicylic acid. Br J Ind Med 49 (1992) 66-69
21. Lai J.C., Minski M.J., Chan A.W., Leung T.K., and Lim L. Manganese mineral interactions in brain. NeuroToxicology 20 (1999) 433-444
22. Lee J.W. Manganese intoxication. Arch Neurol 57 (2000) 597-599
23. Li G.J., Zhang L.L., Lu L., Wu P., and Zheng W. Occupational exposure to welding fume among welders: alterations of manganese, iron, zinc, copper, and lead in body fluids and the oxidative stress status. J Occup Environ Med 46 (2004) 241-248
24. Li G.J., Zhao Q., and Zheng W. Alteration at translational but not transcriptional level of transferrin receptor expression following manganese exposure at the blood-CSF barrier in vitro. Toxicol Appl Pharmacol 205 (2005) 188-200
25. Li G.J., Choi B.S., Wang X., Liu J., Waalkes M.P., and Zheng W. Molecular mechanism of distorted iron regulation in the choroids plexus and selected brain regional capillaries following in vivo manganese exposure. NeuroToxicology 27 (2006) 737-744
26. Liccione J., and Maines M. Selective vulnerability of glutathione metabolism and cellular defense mechanisms in rat striatum to manganese. J Pharmacol Exp Ther 247 (1988) 156-161
27. Mena I., Court J., Fuenzalida S., Papavasiliou P.S., and Cotzias G.C. Modification of chronic manganese poisoning. Treatment with l-dopa or 5-OH tryptophane. N Engl J Med 282 (1970) 5-10
28. Michalke B., Berthele A., Mistriotis P., Ochsenkuhn-Petropoulou M., and Halbach S. Manganese speciation in human cerebrospinal fluid using CZE coupled to inductively coupled plasma MS. Electrophoresis 28 (2007) 1380-1386
29. Murphy V.A., Wadhwani K.C., Smith Q.R., and Rapoport S.I. Saturable transport of manganese(II) across the rat blood-brain barrier. J Neurochem 57 (1991) 948-954
30. Myers J.E., Thompson M.L., Ramushu S., Young T., Jeebhay M.F., London L., et al. The nervous system effects of occupational exposure on workers in a South African manganese smelter. NeuroToxicology 24 (2003) 885-894
31. Nagatomo S., Umehara F., Hanada K., Nobuhara Y., Takenaga S., Arimura K., et al. Manganese intoxication during total parenteral nutrition: report of two cases and review of the literature. J Neurol Sci 162 (1999) 102-105
32. Ono K., Komai K., and Yamada M. Myoclonic involuntary movement associated with chronic manganese poisoning. J Neurol Sci 199 (2002) 93-96
33. Peloquin C.A., Zhu M., Adam R.D., Singleton M.D., and Nix D.E. Pharmacokinetics of para-aminosalicylic acid granules under four dosing conditions. Ann Pharmacother 35 (2001) 1332-1338
34. Physicians' Desk Reference. Montvale: Medical Economics Company; 2000. p. 1443-4.
35. Ponnapakkam T., Iszard M., and Henry-Sam G. Effects of oral administration of manganese on the kidneys and urinary bladder of Sprague-Dawley rats. Int J Toxicol 22 (2003) 227-232
36. Rabin O., Hegedus L., Bourre J.M., and Smith Q.R. Rapid brain uptake of manganese(II) across the blood-brain barrier. J Neurochem 61 (1993) 509-517
37. Reaney S.H., Bench G., and Smith D.R. Brain accumulation and toxicity of Mn(II) and Mn(III) exposures. Toxicol Sci 93 (2006) 114-124
38. Rengarajan J., Sassetti C.M., Naroditskaya V., Sloutsky A., Bloom B.R., and Rubin E.J. The folate pathway is a target for resistance to the drug para-aminosalicylic acid (PAS) in mycobacteria. Mol Microbiol 53 (2004) 275-282
39. 2) on the absorption and cerebral distribution of manganese in rats. Arch Toxicol 71 (1997) 223-230
40. Rosenstock H.A., Simons D.G., and Meyer J.S. Chronic manganism. Neurologic and laboratory studies during treatment with levodopa. JAMA 217 (1971) 1354-1358
41. Sanchez D.J., Gomez M., Domingo J.L., Llobet J.M., and Corbella J. Relative efficacy of chelating agents on excretion and tissue distribution of manganese in mice. J Appl Toxicol 15 (1995) 285-288
42. Schlageter N.L., Carson R.E., and Rapoport S.I. Examination of blood-brain barrier permeability in dementia of the Alzheimer type with [68Ga]EDTA and positron emission tomography. J Cereb Blood Flow Metab 7 (1987) 1-8
43. Seth P.K., Husain R., Mushtaq M., and Chandra S.V. Effect of manganese on neonatal rat: manganese concentration and enzymatic alterations in brain. Acta Pharmacol Toxicol 40 (1977) 553-560
44. Seth P.K., Hong J.S., Kilts C.D., and Bondy S.C. Alteration of cerebral neurotransmitter receptor function by exposure of rats to manganese. Toxicol Lett 9 (1981) 247-254
45. Spector R., and Loremzo A.V. The active transport of para-aminosalicylic acid from the cerebrospinal fluid. J Pharm Exp Ther 85 (1973) 642-648
46. Tandon S.K., Chandra S.V., Singh J., Husain R., and Seth P.K. Chelation in metal intoxication. I. In vivo effect of chelating agents on liver and testes of manganese administered rats. Environ Res 9 (1975) 18-25
47. Tandon S.K., and Singh J. Removal of manganese by chelating agents from brain and liver of manganese treated rats: an in vitro and an in vivo study. Toxicology 5 (1975) 237-241
48. 2. Toxicology 9 (1978) 379-385
49. Thomsen H.S., Svendsen O., and Klastrup S. Increased manganese concentration in the liver after oral intake. Acad Radiol 11 (2004) 38-44
50. Wan S.H., Pentikainen P., and Azarnoff D.L. Bioavailability studies on para-aminosalicylic acid and its various salts in man. I. Absorption from solution and suspension. J Pharmacokinet Pharmacodyn 2 (1974) 1-12
51. Wang X.Q., Miller D.S., and Zheng W. Intracellular trafficking of metal transporters in intact rat choroid plexus following in vitro treatment of manganese or iron. Toxicol Appl Pharmacol 230 (2008) 167-174
52. Wang X.Q., Li J., and Zheng W. Efflux of iron from the cerebrospinal fluid to the blood at the blood-CSF barrier: Effect of manganese exposure. Exp Biol Med 233 (2008) 1561-1571
53. Wang D.X., Du X.Q., and Zheng W. Alteration of saliva and serum concentrations of manganese, copper, zinc, cadmium and lead among career welders. Toxicol Letters 176 (2008) 40-47
54. Yamada M., Ohno S., Okayasu I., Hatakeyama S., Watanabe H., Ushio K., et al. Chronic manganese poisoning: a neuropathological study with determination of manganese distribution in the brain. Acta Neuropathol (Berl) 70 (1986) 273-278
55. Zhao Q., Slavkovich V., and Zheng W. Lead exposure promotes translocation of protein kinase C activity in rat choroid plexus in vitro, but not in vivo. Toxicol Appl Pharmacol 149 (1998) 99-106
56. Zheng W., Shen H., Blaner S.B., Zhao Q., Ren X., and Graziano J.H. Chronic lead exposure alters transthyretin concentration in rat cerebrospinal fluid: the role of the choroid plexus. Toxicol Appl Pharmacol 139 (1996) 445-450
57. Zheng W., Ren S., and Graziano J.H. Manganese inhibits mitochondrial aconitase: a mechanism of manganese neurotoxicity. Brain Res 799 (1998) 334-342
58. Zheng W., Zhao Q., Slavkovich V., Aschner M., and Graziano J.H. Alteration of iron homeostasis following chronic exposure to manganese in rats. Brain Res 833 (1999) 125-132
59. Zheng W., and Zhao Q. Iron overload following manganese exposure in cultured neuronal, but not neuroglial cells. Brain Res 897 (2001) 175-179
60. Zheng W., Aschner M., and Ghersi-Egea J.F. Brain barrier systems: a new frontier in metal neurotoxicological research. Toxicol Appl Pharmacol 192 (2003) 1-11